Blood cancer patients should continue BTKi therapy during COVID-19 vaccination

Blood cancer patients should continue BTKi therapy during COVID-19 vaccination

Source: News-Medical

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study suggests.

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study suggests.
The findings of a clinical trial led by the University of Birmingham and the Oxford Clinical Tr… [2981 chars]

Read more

Leave a Comment

Your email address will not be published.

0